What You and Your Patients Need to Know About Vitamin D

Seminars in Cutaneous Medicine and Surgery

Volumn 31, Issue 1, 2012, Pages 2-10

  Powers, Jennifer G ^a   Gilchrest, Barbara A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Photoprotection; Vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CALCITRIOL; CALCIUM; CARCINOGEN; CATHELICIDIN; COLECALCIFEROL; CYCLIN DEPENDENT KINASE; DIHYDROLANOSTEROL; ERGOCALCIFEROL; OMEGA 3 FATTY ACID; PARATHYROID HORMONE; RETINOBLASTOMA PROTEIN; VITAMIN D; VITAMIN D RECEPTOR;

AUTISM; AUTOIMMUNITY; BLOOD VESSEL CALCIFICATION; BREAST CANCER; CALCIUM HOMEOSTASIS; CANCER MORTALITY; CELL MEMBRANE; CONSTIPATION; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG MARKETING; DRUG MEGADOSE; EPIDERMIS; FOOD; HEALTH HAZARD; HUMAN; HYPERCALCEMIA; IMMUNITY; IRON ABSORPTION; MELANOMA; MUSCULOSKELETAL SYSTEM; NEOPLASM; NEPHROLITHIASIS; NONHUMAN; PARKINSON DISEASE; PHOTOSYNTHESIS; PREVALENCE; PROTEIN PHOSPHORYLATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SKIN CANCER; SOFT TISSUE CALCIFICATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

AGE FACTORS; CALCIUM; DIETARY SUPPLEMENTS; HOMEOSTASIS; HUMANS; IMMUNITY; MUSCULOSKELETAL PHYSIOLOGICAL PHENOMENA; NEOPLASMS; NUTRITION POLICY; PROSPECTIVE STUDIES; SEX FACTORS; SUNLIGHT; SUNSCREENING AGENTS; ULTRAVIOLET RAYS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84857213071     PISSN: 10855629     EISSN: 15580768     Source Type: Journal    
DOI: 10.1016/j.sder.2011.11.008     Document Type: Review

References (113)

1. Parker-Pope T. The miracle of vitamin D: Sound science, or hype? February 1, 2010, The New York Times.
2. Vitamin D sales strong in 2010. Nutr Bus J 2011.
3. Vitamins D is, 2009: Sales star. Nutr Bus J 2011.
4. Gilchrest B. Anti-sunshine vitamin A. Nat Med 1999, 5:376-377.
5. Wolpowitz D., Gilchrest B.A. The vitamin D questions: How much do you need and how should you get it?. J Am Acad Dermatol 2006, 54:301-317.
6. Fry A., Verne J. Preventing skin cancer. BMJ 2003, 326:114-115.
7. Young A.R. Tanning devices-Fast track to skin cancer?. Pigment Cell Res 2004, 17:2-9.
8. Albert M.R., Ostheimer K.G. The evolution of current medical and popular attitudes toward ultraviolet light exposure: part 3. J Am Acad Dermatol 2003, 49:1096-1106.
9. El Ghissassi F., Baan R., Straif K., et al. A review of human carcinogens-Part D: Radiation. Lancet Oncol 2009, 10:751-752.
10. Position statement on indoor tanning AAD, Accessed August 17, 2011. http://www.aad.org/skin-care-and-safety/skin-cancer-prevention/indoor-tanning/the-dangers-of-indoor-tanning.
11. Rogers H.W., Weinstock M.A., Harris A.R., et al. Incidence estimate of nonmelanoma skin cancer in the United States. Arch Dermatol 2006, 2010:283-287.
12. Melanoma AAD, Accessed August 5, 2011. http://www.aad.org/media-resources/stats-and-facts/conditions/melanoma/melanoma.
13. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium 2010, Institute of Medicine, Washington, DC. A.C. Ross, L.C. Taylor, L.A. Yaktine, H.B. Del Valle (Eds.).
14. Ross A.C., Manson J.E., Abrams S.A., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab 2011, 96:53-58.
15. Fieser L.F., Fieser M. Vitamin D 1959, Reinhold, New York.
16. Jones G., Strugnell S.A., DeLuca H.F. Current understanding of the molecular actions of vitamin D. Physiol Rev 1998, 78:1193-1231.
17. Jurutka P.W., Whitfield G.K., Hsieh J.C., et al. Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Disord 2001, 2:203-216.
18. Galitzer H., Ben-Dov I., Lavi-Moshayoff V., et al. Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion. Curr Opin Nephrol Hypertens 2008, 17:363-367.
19. Bergwitz C., Jüppner H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 2010, 61:91-104.
20. Rosen C.J. Clinical practice. Vitamin D insufficiency. N Engl J Med 2011, 364:248-254.
21. DeLuca H.F. The vitamin D story: A collaborative effort of basic science and clinical medicine. FASEB J 1988, 2:224-236.
22. Reichel H., Koeffler H.P., Norman A.W. The role of the vitamin D endocrine system in health and disease. N Engl J Med 1989, 320:980-991.
23. Adams J.S., Hewison M. Unexpected actions of vitamin D: New perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008, 4:80-90.
24. Masuda S., Byford V., Arabian A., et al. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Endocrinology 2005, 146:825-834.
25. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
26. Liu P.T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
27. Koga M., Eisman J.A., Sutherland R.L. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells. Cancer Res 1988, 48:2734-2739.
28. Kawa S., Yoshizawa K., Tokoo M., et al. Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines. Gastroenterology 1996, 110:1605-1613.
29. Campbell M.J., Elstner E., Holden S., et al. Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21WAF1, p27Kip1 and E-cadherin. J Mol Endocrinol 1997, 19:15-27.
30. Xie S.P., James S.Y., Colston K.W. Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells. J Endocrinol 1997, 154:495-504.
31. Yanagisawa J., Yanagi Y., Masuhiro Y., et al. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 1999, 283:1317-1321.
32. Gaschott T., Stein J. Short-chain fatty acids and colon cancer cells: The vitamin D receptor-Butyrate connection. Recent Results Cancer Res 2003, 164:247-257.
33. Li P., Li C., Zhao X., et al. p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-cullin-F-box protein/Skp2 ubiquitin ligase. J Biol Chem 2004, 279:25260-25267.
34. MacLaughlin J., Holick M.F. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985, 76:1536-1538.
35. Holick M.F., MacLaughlin J.A., Doppelt S.H. Regulation of cutaneous previtamin d3 photosynthesis in man: Skin pigment is not an essential regulator. Science 1981, 211:590-593.
36. Vieth R. The mechanisms of vitamin D toxicity. Bone Miner 1990, 11:267-272.
37. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 2008, 88:582S-586S.
38. Agency information collection activities; submission for office of management and budget review; comment request; food labeling regulations. Fed Regist 2009, 74:53743-53746. FDA.
39. Thompson G.R., Lewis B., Booth C.C. Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption. J Clin Invest 1966, 45:94-102.
40. Blomstrand R., Forsgren L. Intestinal absorption and esterification of vitamin D3-1,2-3H in man. Acta Chem Scand 1967, 21:1662-1663.
41. Compston J.E., Merrett A.L., Hammett F.G., et al. Comparison of the appearance of radiolabelled vitamin D3 and 25-hydroxy-vitamin D3 in the chylomicron fraction of plasma after oral administration in man. Clin Sci (Lond) 1981, 60:241-243.
42. James W.P., Avenell A., Broom J., et al. A one-year trial to assess the value of orlistat in the management of obesity. Int J Obes Relat Metab Disord 1997, 3(21 Suppl):S24-S30.
43. McDuffie J.R., Calis K.A., Booth S.L., et al. Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy 2002, 22:814-822.
44. Schoenmakers I., Goldberg G.R., Prentice A. Abundant sunshine and vitamin D deficiency. Br J Nutr 2008, 99. 117-113.
45. Bischoff-Ferrari H.A., Giovannucci E., Willet W.C., et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006, 84:118-128.
46. Hollis B.W., Wagner C.L., Drezner M.K., et al. Circulating vitamin D3 and 25-hydroxyvitamin D in humans: An important tool to define adequate nutritional vitamin D status. J Steroid Biochem Mol Biol 2007, 103:631-634.
47. Scientists call to action regarding vitamin D Accessed August 15, 2011. http://www.grassrootshealth.net/call-to-action.
48. Cranney A., Horsley T., O'Donnell S., et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 2007, 158:1-235.
49. Cherniack E.P., Florez H.J., Hollis B.W., et al. The response of elderly veterans to daily vitamin D3 supplementation of 2,000 IU: A pilot efficacy study. J Am Geriatr Soc 2011, 59:286-290.
50. Position statement of vitamin D AAD, Accessed: August 18, 2011. http://www.aad.org/media-resources/stats-and-facts/prevention-and-care/vitamin-d/vitamin-d.
51. Reddy K.K., Gilchrest B.A. What is all this commotion about vitamin D?. J Invest Dermatol 2010, 130:321-326.
52. Rapuri P.B., Kinyamu H.K., Gallagher J.C., et al. Seasonal changes in calciotropic hormones, bone markers, and bone mineral density in elderly women. J Clin Endocrinol Metab 2002, 87:2024-2032.
53. Looker A.C., Pfeiffer C.M., Lacher D.A., et al. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008, 88:1519-1527.
54. Holick M.F. Skin: Site of the synthesis of vitamin D and a target tissue for the active form, 1,25-dihydroxyvitamin D3. Ann N Y Acad Sci 1988, 548:14-26.
55. Diehl J.W., Chiu M.W. Effects of ambient sunlight and photoprotection on vitamin D status. Dermatol Ther 2010, 23:48-60.
56. Springbett P., Buglass S., Young A.R. Photoprotection and vitamin D status. J Photochem Photobiol B Biol 2010, 101:160-168.
57. Norval M., Wulf H.C. Does chronic sunscreen use reduce vitamin D production to insufficient levels?. Br J Dermatol 2009, 161:732-736.
58. Diffey B.L. Modelling the seasonal variation of vitamin D due to sun exposure. Br J Dermatol 2010, 162:1342-1348.
59. Bogh M.K., Schmedes A.V., Philipsen P.A., et al. Interdependence between body surface area and ultraviolet B dose in vitamin D production: A randomized controlled trial. Br J Dermatol 2011, 164:163-169.
60. Behavioral Counseling to Prevent Skin Cancer: Systematic Evidence Review to Update the 2003 US Preventive Services Task Force Recommendation 2011, Agency for Healthcare Research and Quality, US Department of Health and Human Services, Rockville, MD.
61. Freedman D.M., Looker A.C., Abnet C.C., et al. Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res 2010, 70:8587-8597.
62. Rohan T.E., Negassa A., Chlebowski R.T., et al. A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease. Breast Cancer Res Treat 2009, 116:339-350.
63. Washington M.N., Weigel N.L. 1{alpha},25-dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion. Endocrinology 2010, 151:1409-1417.
64. Gilbert R., Martin R.M., Beynon R., et al. Associations of circulating and dietary vitamin D with prostate cancer risk: A systematic review and dose-response meta-analysis. Cancer Causes Control 2011, 22:319-340.
65. Meyer F., Liu G., Douville P., et al. Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients. Int J Cancer 2011, 128:1741-1746.
66. Gandini S., Boniol M., Haukka J., et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011, 128:1414-1424.
67. Jenab M., Bueno-de-Mesquita H.B., Ferrari P., et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ 2010, 340:b5500.
68. Ng K., Sargent D.J., Goldberg R.M., et al. Vitamin D status in patients with stage IV colorectal cancer: Findings from intergroup trial N9741. J Clin Oncol 2011, 29:1599-1606.
69. Wactawski-Wende J., Kotchen J.M., Anderson G.L., et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006, 354:684-696.
70. Chang E.T., Canchola A.J., Cockburn M., et al. Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California teachers study. Blood 2011, 118:1591-1599.
71. Tang J.Y., Fu T., Leblanc E., et al. Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: Post hoc analyses of the women's health initiative randomized controlled trial. J Clin Oncol 2011, 29:3078-3084.
72. Eide MJ, Johnson DA, Jacobsen GR, et al: Vitamin D and nonmelanoma skin cancer in a health maintenance organization cohort. Arch Dermatol (in press).
73. Zittermann A., Schleithoff S.S., Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005, 94:483-492.
74. Trivedi D.P., Doll R., Khaw K.T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: Randomised double blind controlled trial. BMJ 2003, 326:469.
75. Bolland M.J., Grey A., Avenell A., et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: Reanalysis of the women's health initiative limited access dataset and meta-analysis. BMJ 2011, 342:d2040.
76. Witham M.D., Crighton L.J., Gillespie N.D., et al. The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: A randomized controlled trial. Circ Heart Fail 2010, 3:195-201.
77. Jorde R., Sneve M., Torjesen P., et al. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010, 267:462-472.
78. Martineau A.R., Timms P.M., Bothamley G.H., et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: A double-blind randomised controlled trial. Lancet 2011, 377:242-250.
79. Kerr G.S., Sabahi I., Richards J.S., et al. Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J Rheumatol 2011, 38:53-59.
80. Llewellyn D.J., Langa K.M., Lang I.A. Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 2009, 22:188-195.
81. Evatt M.L., DeLong M.R., Kumari M., et al. High prevalence of hypovitaminosis D status in patients with early Parkinson disease. Arch Neurol 2011, 68:314-319.
82. Mosher C.E., Danoff-Burg S. Addiction to indoor tanning: Relation to anxiety, depression, and substance use. Arch Dermatol 2010, 146:412-417.
83. Cui R., Widlund H.R., Feige E., et al. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 2007, 128:853-864.
84. Pan A., Lu L., Franco O.H., et al. Association between depressive symptoms and 25-hydroxyvitamin D in middle-aged and elderly Chinese. J Affect Disord 2009, 118:240-243.
85. Haugen M., Brantsaeter A.L., Trogstad L., et al. Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology 2009, 20:720-726.
86. Hyppönen E., Hartikainen A.L., Sovio U., et al. Does vitamin D supplementation in infancy reduce the risk of pre-eclampsia?. Eur J Clin Nutr 2007, 61:1136-1139.
87. Brooke O.G., Brown I.R., Bone C.D., et al. Vitamin D supplements in pregnant Asian women: Effects on calcium status and fetal growth. Br Med J 1980, 280:751-754.
88. Delvin E.E., Salle B.L., Glorieux F.H., et al. Vitamin D supplementation during pregnancy: Effect on neonatal calcium homeostasis. J Pediatr 1986, 109:328-334.
89. Chung M., Balk E.M., Brendel M., et al. Vitamin D and calcium: A systematic review of health outcomes. Evid Rep Technol Assess (Full Rep) 2009, 183:1-420.
90. Kärkkäinen M., Tuppurainen M., Salovaara K., et al. Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: A 3-year randomized population-based trial (OSTPRE-FPS). Osteoporos Int 2010, 21:2047-2055.
91. Dawson-Hughes B., Harris S.S., Krall E.A., et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997, 337:670-676.
92. Chapuy M.C., Arlot M.E., Duboeuf F., et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992, 327:1637-1642.
93. Chapuy M.C., Arlot M.E., Delmas P.D., et al. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994, 308:1081-1082.
94. Heikinheimo R.J., Inkovaara J.A., Harju E.J., et al. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 1992, 51:105-110.
95. Larsen E.R., Mosekilde L., Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: A pragmatic population-based 3-year intervention study. J Bone Miner Res 2004, 19:370-378.
96. Sato Y., Iwamoto J., Kanoko T., et al. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: A randomized controlled trial. Cerebrovasc Dis 2005, 20:187-192.
97. Chapuy M.C., Pamphile R., Paris E., et al. Combined calcium and vitamin D3 supplementation in elderly women: Confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: The Decalyos II study. Osteoporos Int 2002, 13:257-264.
98. Meyer H.E., Smedshaug G.B., Kvaavik E., et al. Can vitamin D supplementation reduce the risk of fracture in the elderly?. A randomized controlled trial. J Bone Miner Res 2002, 17:709-715.
99. Gallagher J.C. The effects of calcitriol on falls and fractures and physical performance tests. J Steroid Biochem Mol Biol 2004, 89-90:497-501.
100. Grant A.M., Avenell A., Campbell M.K., et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (randomised evaluation of calcium or vitamin D, RECORD): A randomised placebo-controlled trial. Lancet 2005, 365:1621-1628.
101. Lips P., Graafmans W.C., Ooms M.E., et al. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med 1996, 124:400-406.
102. Porthouse J., Cockayne S., King C., et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005, 330:1003.
103. Campbell A.J., Robertson M.C., La Grow S.J., et al. Randomised controlled trial of prevention of falls in people aged > or = 75 with severe visual impairment: The VIP trial. BMJ 2005, 331:817.
104. Flicker L., MacInnis R.J., Stein M.S., et al. Should older people in residential care receive vitamin D to prevent falls?. Results of a randomized trial. J Am Geriatr Soc 2005, 53:1881-1888.
105. Jackson R.D., LaCroix A.Z., Gass M., et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006, 354:669-683.
106. Law M., Withers H., Morris J., et al. Vitamin D supplementation and the prevention of fractures and falls: Results of a randomised trial in elderly people in residential accommodation. Age Ageing 2006, 35:482-486.
107. Lyons R.A., Johansen A., Brophy S., et al. Preventing fractures among older people living in institutional care: A pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos Int 2007, 18:811-818.
108. Smith H., Anderson F., Raphael H., et al. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women-A population-based, randomized, double-blind, placebo-controlled trial. Rheumatol Oxf Engl 2007, 46:1852-1857.
109. Sanders K.M., Stuart A.L., Williamson E.J., et al. Annual high-dose oral vitamin D and falls and fractures in older women: A randomized controlled trial. JAMA 2010, 303:1815-1822.
110. Avenell A., Gillespie W.J., Gillespie L.D., et al. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2009, 2. CD000227.
111. Pfeifer M., Begerow B., Minne H.W., et al. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 2000, 15:1113-1118.
112. Pfeifer M., Begerow B., Minne H.W., et al. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 2009, 20:315-322.
113. Bjelakovic G., Gluud L.L., Nikolova D., et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2011, 7. CD007470.